Clinical Trial Update: Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized. [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating intracoronary infusion of autologous bone marrow mononuclear cells in patients with chronic coronary occlusion and ventricular dys…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Atherosclerosis and Other Heart Disease

Drugs mentioned

• Autologous bone marrow mononuclear cells (bone marrow mononuclear cells)

Snippet

Sponsor: Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Conditions: Coronary Atherosclerosis and Other Heart Disease | Phase 2, Phase 3 | Status: COMPLETED